255 related articles for article (PubMed ID: 16333707)
21. Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT).
Cameron K; Golan S; Simpson W; Peti S; Roayaie S; Labow D; Kostakoglu L
Abdom Imaging; 2011 Aug; 36(4):463-71. PubMed ID: 21465110
[TBL] [Abstract][Full Text] [Related]
22. PET imaging in assessing gastrointestinal tumors.
Hustinx R
Radiol Clin North Am; 2004 Nov; 42(6):1123-39, ix. PubMed ID: 15488562
[TBL] [Abstract][Full Text] [Related]
23. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
24. 18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies.
Chin BB; Wahl RL
Gut; 2003 Jun; 52 Suppl 4(Suppl 4):iv23-9. PubMed ID: 12746265
[TBL] [Abstract][Full Text] [Related]
25. Gastrointestinal tract malignancies and positron emission tomography: an overview.
Esteves FP; Schuster DM; Halkar RK
Semin Nucl Med; 2006 Apr; 36(2):169-81. PubMed ID: 16517238
[TBL] [Abstract][Full Text] [Related]
26. FDG-PET/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy.
Veit-Haibach P; Antoch G; Beyer T; Stergar H; Schleucher R; Hauth EA; Bockisch A
Br J Radiol; 2007 Jul; 80(955):508-15. PubMed ID: 17537758
[TBL] [Abstract][Full Text] [Related]
27. Computed tomography in the diagnosis and staging of cholangiocarcinoma and pancreatic carcinoma.
Freeny PC
Ann Oncol; 1999; 10 Suppl 4():12-7. PubMed ID: 10436776
[TBL] [Abstract][Full Text] [Related]
28. PET and PET/CT in the clinical management of colorectal cancer.
El-Maghraby T
Gulf J Oncolog; 2009 Jul; (6):8-16. PubMed ID: 20194086
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer.
Larson SM; Schoder H; Yeung H
Cancer J; 2004; 10(4):243-50. PubMed ID: 15383205
[TBL] [Abstract][Full Text] [Related]
30. Cholangiolocellular Carcinoma of the Liver Exhibiting High F-18 FDG Uptake.
Mori N; Ichikawa T; Hashimoto J; Yamashita T; Yamada M; Hirabayashi K; Imai Y
Tokai J Exp Clin Med; 2016 Jun; 41(2):60-4. PubMed ID: 27344994
[TBL] [Abstract][Full Text] [Related]
31. Value of fusing PET plus CT images in hepatocellular carcinoma and combined hepatocellular and cholangiocarcinoma patients with extrahepatic metastases: preliminary findings.
Nagaoka S; Itano S; Ishibashi M; Torimura T; Baba K; Akiyoshi J; Kurogi J; Matsugaki S; Inoue K; Tajiri N; Takada A; Ando E; Kuromatsu R; Kaida H; Kurogi M; Koga H; Kumashiro R; Hayabuchi N; Kojiro M; Sata M
Liver Int; 2006 Sep; 26(7):781-8. PubMed ID: 16911459
[TBL] [Abstract][Full Text] [Related]
32. Combined hepatocellular carcinoma and cholangiocarcinoma with high F-18 fluorodeoxyglucose positron emission tomographic uptake.
Shiomi S; Sasaki N; Kawashima D; Jomura H; Fukuda T; Kuroki T; Koyama K; Kawabe J; Ochi H
Clin Nucl Med; 1999 May; 24(5):370-1. PubMed ID: 10232488
[No Abstract] [Full Text] [Related]
33. [Combined FDG PET/CT imaging for restaging of colorectal cancer patients: impact of image fusion on staging accuracy].
Strunk H; Bucerius J; Jaeger U; Joe A; Flacke S; Reinhardt M; Hortling N; Palmedo H
Rofo; 2005 Sep; 177(9):1235-41. PubMed ID: 16123869
[TBL] [Abstract][Full Text] [Related]
34. Role of 18F-fluorodeoxyglucose PET in the study of neuroendocrine tumors.
Panagiotidis E; Bomanji J
PET Clin; 2014 Jan; 9(1):43-55. PubMed ID: 25029933
[TBL] [Abstract][Full Text] [Related]
35. PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer.
Vikram R; Iyer RB
Cancer Imaging; 2008 Oct; 8 Spec No A(Spec Iss A):S46-51. PubMed ID: 18852081
[TBL] [Abstract][Full Text] [Related]
36. Gastric Schwannoma mimicking malignant gastrointestinal stromal tumor and misdiagnosed by (18)F-FDG PET/CT.
Zhang Y; Li B; Cai L; Hou X; Shi H; Hou J
Hell J Nucl Med; 2015; 18(1):74-6. PubMed ID: 25840576
[TBL] [Abstract][Full Text] [Related]
37. Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies.
Reinhardt MJ; Strunk H; Gerhardt T; Roedel R; Jaeger U; Bucerius J; Sauerbruch T; Biersack HJ; Dumoulin FL
J Nucl Med; 2005 Jul; 46(7):1158-63. PubMed ID: 16000285
[TBL] [Abstract][Full Text] [Related]
38. [X-ray computed tomography of the biliary tract--the diagnostic images and application of dynamic CT, cholangiography CT, and 3D CT].
Ryu M; Shibuya Y; Kikuchi T; Maruyama T; Shinohara Y; Yamamoto H
Rinsho Hoshasen; 1989 Sep; 34(10):1139-52. PubMed ID: 2689708
[No Abstract] [Full Text] [Related]
39. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.
Anderson CD; Rice MH; Pinson CW; Chapman WC; Chari RS; Delbeke D
J Gastrointest Surg; 2004 Jan; 8(1):90-7. PubMed ID: 14746840
[TBL] [Abstract][Full Text] [Related]
40. [Imaging for hepato-pancreatico-biliary diseases - a short review].
Banz VM; Candinas D
Ther Umsch; 2009 Jan; 66(1):31-8. PubMed ID: 19105153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
